PTC Therapeutics (PTCT) News Today $66.80 +0.28 (+0.42%) Closing price 04:00 PM EasternExtended Trading$66.70 -0.10 (-0.15%) As of 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PTCT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period VIRGINIA RETIREMENT SYSTEMS ET Al Invests $1.55 Million in PTC Therapeutics, Inc. $PTCTOctober 23 at 4:55 AM | marketbeat.comPTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial ResultsOctober 21 at 8:00 AM | prnewswire.comPTC Therapeutics (NASDAQ:PTCT) Coverage Initiated by Analysts at Wells Fargo & CompanyOctober 20 at 8:27 AM | marketbeat.comLeerink Partnrs Has Pessimistic Outlook of PTCT Q1 EarningsOctober 20 at 2:37 AM | americanbankingnews.comLeerink Partnrs Issues Pessimistic Outlook for PTCT EarningsOctober 20 at 2:36 AM | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Sets New 52-Week High - Here's What HappenedOctober 15, 2025 | marketbeat.comPTC Therapeutics, Inc. $PTCT Shares Purchased by Bayforest Capital LtdOctober 14, 2025 | marketbeat.comLeerink Partnrs Issues Positive Outlook for PTCT EarningsOctober 13, 2025 | marketbeat.comInsider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 3,375 Shares of StockOctober 10, 2025 | marketbeat.comPTC Therapeutics' (PTCT) Hold (C-) Rating Reaffirmed at Weiss RatingsOctober 10, 2025 | marketbeat.comMark Elliott Boulding Sells 3,375 Shares of PTC Therapeutics (NASDAQ:PTCT) StockOctober 10, 2025 | insidertrades.comRobeco Institutional Asset Management B.V. Buys Shares of 5,733 PTC Therapeutics, Inc. $PTCTOctober 9, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) VP Sells $147,448.62 in StockOctober 8, 2025 | insidertrades.comMark Elliott Boulding Sells 2,266 Shares of PTC Therapeutics (NASDAQ:PTCT) StockOctober 7, 2025 | marketbeat.comAllan Steven Jacobson Sells 12,000 Shares of PTC Therapeutics (NASDAQ:PTCT) StockOctober 7, 2025 | marketbeat.comMark Elliott Boulding Sells 22,655 Shares of PTC Therapeutics (NASDAQ:PTCT) StockOctober 7, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Director Sells $1,686,069.52 in StockOctober 7, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Insider Sells $3,632,750.00 in StockOctober 7, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Hits New 1-Year High - What's Next?October 2, 2025 | marketbeat.comPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 1, 2025 | prnewswire.comPTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 30, 2025 | marketbeat.comStrs Ohio Takes Position in PTC Therapeutics, Inc. $PTCTSeptember 23, 2025 | marketbeat.comPTC Therapeutics, Inc. $PTCT Shares Bought by Assenagon Asset Management S.A.September 22, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Reaches New 12-Month High - Here's What HappenedSeptember 19, 2025 | marketbeat.comFinanciere des Professionnels Fonds d investissement inc. Makes New $284,000 Investment in PTC Therapeutics, Inc. $PTCTSeptember 19, 2025 | marketbeat.comHarbor Capital Advisors Inc. Grows Stock Position in PTC Therapeutics, Inc. $PTCTSeptember 18, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Director Emma Reeve Sells 15,705 SharesSeptember 17, 2025 | marketbeat.comInsider Selling: PTC Therapeutics (NASDAQ:PTCT) Director Sells 15,705 Shares of StockSeptember 17, 2025 | insidertrades.comIntech Investment Management LLC Buys 15,167 Shares of PTC Therapeutics, Inc. $PTCTSeptember 17, 2025 | marketbeat.comBank of America Securities Keeps Their Buy Rating on PTC Therapeutics (PTCT)September 16, 2025 | theglobeandmail.comPTC Therapeutics (NASDAQ:PTCT) VP Sells $1,382,504.00 in StockSeptember 16, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) VP Mark Elliott Boulding Sells 24,585 SharesSeptember 16, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) VP Sells $1,382,504.00 in StockSeptember 16, 2025 | insidertrades.comPTC Therapeutics, Inc. $PTCT Stake Reduced by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.September 15, 2025 | marketbeat.comEllsworth Advisors LLC Makes New $588,000 Investment in PTC Therapeutics, Inc. $PTCTSeptember 14, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Director David Southwell Sells 12,000 SharesSeptember 13, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Sets New 1-Year High - Here's WhySeptember 13, 2025 | marketbeat.comPTC Therapeutics, Inc. $PTCT Shares Sold by Jacobs Levy Equity Management Inc.September 13, 2025 | marketbeat.comPTC Therapeutics (NASDAQ:PTCT) Director Sells $700,080.00 in StockSeptember 12, 2025 | insidertrades.comBayforest Capital Ltd Purchases New Shares in PTC Therapeutics, Inc. $PTCTSeptember 12, 2025 | marketbeat.comEric Pauwels Sells 39,850 Shares of PTC Therapeutics (NASDAQ:PTCT) StockSeptember 11, 2025 | marketbeat.comPTC Therapeutics, Inc. (PTCT) Launches SUFIANCE for PKUSeptember 11, 2025 | msn.comInsider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 39,850 Shares of StockSeptember 10, 2025 | insidertrades.comAQR Capital Management LLC Boosts Stake in PTC Therapeutics, Inc. $PTCTSeptember 10, 2025 | marketbeat.comCantor Fitzgerald Keeps Their Buy Rating on PTC Therapeutics (PTCT)September 8, 2025 | theglobeandmail.comPTC Therapeutics, Inc. (PTCT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comPTC Therapeutics, Inc. $PTCT Shares Bought by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comPTC Therapeutics, Inc. (PTCT) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 7, 2025 | seekingalpha.comPTC Therapeutics, Inc. (PTCT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeptember 7, 2025 | seekingalpha.comAdage Capital Partners GP L.L.C. Increases Stock Position in PTC Therapeutics, Inc. $PTCTSeptember 7, 2025 | marketbeat.com Get PTC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PTCT Media Mentions By Week PTCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTCT News Sentiment▼-0.300.52▲Average Medical News Sentiment PTCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTCT Articles This Week▼1210▲PTCT Articles Average Week Get the Latest News and Ratings for PTCT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for PTC Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SMMT News ASND News RDY News VTRS News ROIV News QGEN News ELAN News BBIO News MRNA News RVMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PTCT) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PTC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTCT Stock Alerts